DNA/RNA purification system, filtration system, and synthesizer for NCATS (COVID-19)
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 75N95021Q00327
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6630 Chemical Analysis Instruments
Notice details come from SAM.gov. Updated .
About this opportunity
This solicitation requests quotations for the purchase of three laboratory systems to support COVID-19 research at the National Center for Advancing Translational Sciences, National Institutes of Health. The systems sought include one Cytiva AKTA pure 150 M or equivalent purification system, one Cytiva AKTA Oligopilot 100 or equivalent synthesis system, and one Cytiva AKTAcrossflow or equivalent ultrafiltration system. Quotations are due by July 27, 2021 and will be evaluated based on technical capability, price, terms and conditions, and past performance, with award anticipated by July 30, 2021.
There is no set-aside restriction for this procurement using simplified acquisition procedures for commercial items. The associated NAICS code is 334516 for analytical laboratory instrument manufacturing. Delivery within 60 days of order is required to the National Institutes of Health campus in Rockville, Maryland. Responses shall include fixed prices for the specified equipment and shipping, with evaluation comparing bona fide capabilities to meet the stated requirements at the most advantageous price.
Notice text
2 versions
Update #2 · Latest ·
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
(ii) The solicitation number is 75N95021Q00327 and the solicitation is issued as a request for quotation (RFQ).
This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; FAR Subpart 13.5— Simplified Procedures for Certain Commercial Items; and FAR Part 12—Acquisition of Commercial Items, and is expected to exceed the simplified acquisition threshold. The Government anticipates award of a firm fixed-price contract for this acquisition, and the anticipated award date is around July 30, 2021.
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2021-06 dated July 12, 2021.
(iv) This acquisition is full and open with no set-aside restrictions. The associated NAICS code is 334516 and the small business size standard is 1,000 employees.
(v) This acquisition is for the following list of contract line item numbers (CLINs) and items, quantities, and units of measure (including option(s), if applicable):
Cytiva’s AKTA pure 150 M or brand-equal system, quantity: one (1).
Cytiva’s AKTA Oligopilot 100 or brand-equal system, quantity: one (1).
Cytiva’s AKTAcrossflow or brand-equal system (new or repurposed), quantity: one (1).
(vi) The purchase description with salient characteristics is included as Attachment 1 to this Solicitation.
(vii) The place of delivery and acceptance shall be:
The National Center for Advancing Translational Sciences (NCATS)
9800 Medical Center Drive
Rockville, MD 20850
Delivery shall be within sixty (60) days after receipt of order (ARO) and Contractor shall provide inside delivery. Delivery will be f.o.b. destination, and the quotation’s total price must include all shipping and handling costs.
PROVISIONS, CLAUSES, AND OTHER TERMS AND CONDITIONS
(viii) The provision at FAR clause 52.212-1, Instructions to Offerors – Commercial Items (Tailored), applies to this acquisition and is attached in full text.
(ix) The Government will perform a comparative evaluation of responses in accordance with FAR 13.106-2(b)(3) and award a contract from this solicitation to the responsible offeror whose response meets the solicitation’s requirements and, as a whole, will be most advantageous to the Government, price and other factors considered. The evaluation will compare:
- Technical Capability of the items to meet the Government requirement
- Price,
- Terms and Conditions, and
- Past Performance as defined under FAR 13.106-2(b)(3).
If only one quotation is received it will be evaluated on the above.
Responses may exceed capability or performance characteristics of the solicitation’s requirements. The Government reserves the right, but is not required, to award to a response that exceeds capability or performance characteristics of the solicitation’s requirements if it provides a benefit to the Government.
(x) Offerors are to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Items, with offers.
(xi) The clause at FAR 52.212-4, Contract Terms and Conditions-Commercial Items, applies to this acquisition.
The following FAR and HHSAR provisions and clauses are accessible electronically at https://www.acquisition.gov/, apply to this acquisition, and are incorporated by reference:
FAR 52.204-7, System for Award Management (Oct 2018)
FAR 52.204-13, System for Award Management Maintenance (Oct 2018)
FAR 52.204-16, Commercial and Government Entity Code Reporting (Aug 2020)
FAR 52.204-18, Commercial and Government Entity Code Maintenance (Aug 2020)
FAR 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Oct 2020)
FAR 52.204-26, Covered Telecommunications Equipment or Services-Representation (Oct 2020)
FAR 52.211-6, Brand Name or Equal (Aug 1999)
FAR 52.214-34, Submission of Offers in the English Language (Apr 1991)
FAR 52.214-35, Submission of Offers in U.S. Currency (Apr 1991)
FAR 52.225-6, Trade Agreements Certificate (Feb 2021)>
HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 18, 2015)
The following apply to this acquisition and are incorporated in full text as attachments:
NIH Invoice and Payment Provisions and Electronic Invoicing Instructions for NIH Contractors/Vendors (2/10/2021): NIH implementation requirements of the PROMPT PAYMENT clause at FAR 52.232-25. Addendum to these invoicing instructions applies to this acquisition, and the additional instructions to offerors are as follows: The Contractor will invoice after completion of deliveries.
(xii) Theclause at FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition and is attached in full text.
(xiii) One or more of the items under this acquisition are subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements.
(xiv) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement; however, HHS reserves the right to exercise priorities and allocations authority with respect to this contract, to include rating this contract/order in accordance with 45 CFR Part 101, Subpart A - Health Resources Priorities and Allocations System.
SUBMISSION INSTRUCTIONS
(xv) Responses to this solicitation must include sufficient information to establish the interested parties’ bona-fide capabilities of providing the product or service. The response shall contain a quotation that includes the total price, as well as: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s), product description, and any other information or factors that may be considered in the award decision. Such factors may include: past performance, special features required for effective program performance, trade-in considerations, probable life of the item selected as compared with that of a comparable item, warranty considerations, maintenance availability, and environmental and energy efficiency considerations.
Respondents proposing on an equal product of the brand-name product specified in this announcement must provide, as part of their response: (a) product, catalog, model, and/or part number(s); (b) product description; (c) all relevant information and documentation that the item(s) offered meets the salient physical, functional, or performance characteristics as specified in the purchase description; quantity; estimated price or cost; shipping, handling, and/or installation charges; and delivery date after receipt of order.
The Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.
All responses must be received by 05:00 PM, Eastern Time on July 30, 2021 and reference Solicitation Number 75N95021Q00327. Responses must be submitted by email to the Contracting Officer at mark.mcnally@nih.gov.
(xvi) The name and telephone number of the individual to contact for information regarding the solicitation:
Mark McNally, Contracting Officer, 301-827-5869, mark.mcnally@nih.gov.
ATTACHMENTS
- Purchase Description
- FAR 52.212-1, Instructions to Offerors – Commercial Items (Jul 2021) (Tailored)
- FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders–Commercial Items (Jul 2021)
- NIH Invoice and Payment Provisions and Electronic Invoicing Instructions for NIH Contractors/Vendors (2/10/2021)
Update #1 ·
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
(ii) The solicitation number is 75N95021Q00327 and the solicitation is issued as a request for quotation (RFQ).
This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; FAR Subpart 13.5— Simplified Procedures for Certain Commercial Items; and FAR Part 12—Acquisition of Commercial Items, and is expected to exceed the simplified acquisition threshold. The Government anticipates award of a firm fixed-price contract for this acquisition, and the anticipated award date is around July 30, 2021.
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2021-06 dated July 12, 2021.
(iv) This acquisition is full and open with no set-aside restrictions. The associated NAICS code is 334516 and the small business size standard is 1,000 employees.
(v) This acquisition is for the following list of contract line item numbers (CLINs) and items, quantities, and units of measure (including option(s), if applicable):
Cytiva’s AKTA pure 150 M or brand-equal system, quantity: one (1).
Cytiva’s AKTA Oligopilot 100 or brand-equal system, quantity: one (1).
Cytiva’s AKTAcrossflow or brand-equal system (new or repurposed), quantity: one (1).
(vi) The purchase description with salient characteristics is included as Attachment 1 to this Solicitation.
(vii) The place of delivery and acceptance shall be:
The National Center for Advancing Translational Sciences (NCATS)
9800 Medical Center Drive
Rockville, MD 20850
Delivery shall be within sixty (60) days after receipt of order (ARO) and Contractor shall provide inside delivery. Delivery will be f.o.b. destination, and the quotation’s total price must include all shipping and handling costs.
PROVISIONS, CLAUSES, AND OTHER TERMS AND CONDITIONS
(viii) The provision at FAR clause 52.212-1, Instructions to Offerors – Commercial Items (Tailored), applies to this acquisition and is attached in full text.
(ix) The Government will perform a comparative evaluation of responses in accordance with FAR 13.106-2(b)(3) and award a contract from this solicitation to the responsible offeror whose response meets the solicitation’s requirements and, as a whole, will be most advantageous to the Government, price and other factors considered. The evaluation will compare:
- Technical Capability of the items to meet the Government requirement
- Price,
- Terms and Conditions, and
- Past Performance as defined under FAR 13.106-2(b)(3).
If only one quotation is received it will be evaluated on the above.
Responses may exceed capability or performance characteristics of the solicitation’s requirements. The Government reserves the right, but is not required, to award to a response that exceeds capability or performance characteristics of the solicitation’s requirements if it provides a benefit to the Government.
(x) Offerors are to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Items, with offers.
(xi) The clause at FAR 52.212-4, Contract Terms and Conditions-Commercial Items, applies to this acquisition.
The following FAR and HHSAR provisions and clauses are accessible electronically at https://www.acquisition.gov/, apply to this acquisition, and are incorporated by reference:
FAR 52.204-7, System for Award Management (Oct 2018)
FAR 52.204-13, System for Award Management Maintenance (Oct 2018)
FAR 52.204-16, Commercial and Government Entity Code Reporting (Aug 2020)
FAR 52.204-18, Commercial and Government Entity Code Maintenance (Aug 2020)
FAR 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Oct 2020)
FAR 52.204-26, Covered Telecommunications Equipment or Services-Representation (Oct 2020)
FAR 52.211-6, Brand Name or Equal (Aug 1999)
FAR 52.214-34, Submission of Offers in the English Language (Apr 1991)
FAR 52.214-35, Submission of Offers in U.S. Currency (Apr 1991)
FAR 52.225-6, Trade Agreements Certificate (Feb 2021)>
HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 18, 2015)
The following apply to this acquisition and are incorporated in full text as attachments:
NIH Invoice and Payment Provisions and Electronic Invoicing Instructions for NIH Contractors/Vendors (2/10/2021): NIH implementation requirements of the PROMPT PAYMENT clause at FAR 52.232-25. Addendum to these invoicing instructions applies to this acquisition, and the additional instructions to offerors are as follows: The Contractor will invoice after completion of deliveries.
(xii) Theclause at FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition and is attached in full text.
(xiii) One or more of the items under this acquisition are subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements.
(xiv) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement; however, HHS reserves the right to exercise priorities and allocations authority with respect to this contract, to include rating this contract/order in accordance with 45 CFR Part 101, Subpart A - Health Resources Priorities and Allocations System.
SUBMISSION INSTRUCTIONS
(xv) Responses to this solicitation must include sufficient information to establish the interested parties’ bona-fide capabilities of providing the product or service. The response shall contain a quotation that includes the total price, as well as: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s), product description, and any other information or factors that may be considered in the award decision. Such factors may include: past performance, special features required for effective program performance, trade-in considerations, probable life of the item selected as compared with that of a comparable item, warranty considerations, maintenance availability, and environmental and energy efficiency considerations.
Respondents proposing on an equal product of the brand-name product specified in this announcement must provide, as part of their response: (a) product, catalog, model, and/or part number(s); (b) product description; (c) all relevant information and documentation that the item(s) offered meets the salient physical, functional, or performance characteristics as specified in the purchase description; quantity; estimated price or cost; shipping, handling, and/or installation charges; and delivery date after receipt of order.
The Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.
All responses must be received by 03:00 PM, Eastern Time on July 27, 2021 and reference Solicitation Number 75N95021Q00327. Responses must be submitted by email to the Contracting Officer at mark.mcnally@nih.gov.
(xvi) The name and telephone number of the individual to contact for information regarding the solicitation:
Mark McNally, Contracting Officer, 301-827-5869, mark.mcnally@nih.gov.
ATTACHMENTS
- Purchase Description
- FAR 52.212-1, Instructions to Offerors – Commercial Items (Jul 2021) (Tailored)
- FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders–Commercial Items (Jul 2021)
- NIH Invoice and Payment Provisions and Electronic Invoicing Instructions for NIH Contractors/Vendors (2/10/2021)
Files
Notice history
| Notice | Type | Posted |
|---|---|---|
| DNA/RNA purification system, filtration system, and synthesizer for NCATS (COVID-19) | Award Notice | |
| This notice | Solicitation | |
| DNA/RNA purification system, filtration system, and synthesizer for NCATS (COVID-19) | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Combines Synopsis Solicitation- Automated Spatial | Office of Logisitics and Acquisition Operations | No set-aside | |
| NCSS - Bioruptor Pico Sonication Device | Office of Logisitics and Acquisition Operations | No set-aside | |
| NOI - 4D-Nucleofector Core Unit and X Unit | Office of Logisitics and Acquisition Operations | No set-aside | |
| Notice of Intent DNA Synthesizer | — | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity